ArticleIDCases2025
Orthopnea as a trigger for a diagnostic cascade of multiple infectious diseases.
Article in IDCases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dyspnea is a common clinical symptom and cause of outpatient and inpatient presentations to the clinic. Diagnostic and therapeutic challenges appear, when additional diseases appear that are themselves associated with subjectively perceptible dyspnea. We report on a young woman with orthopnea as a trigger of a diagnostic cascade of various diseases. Case presentation: A 34-year-old woman presented to our emergency department with breathing-dependent, burning thoracic pain, purulent sputum and hemoptysis for three days. Pre-existing diagnoses were psoriasis vulgaris and diabetes mellitus (type 2). Human monoclonal antibody secukinumab and methotrexate were regular drugs.We suspected a community-acquired pneumonia or bacterial co-infection of acute COVID-19. A bronchoalveolar lavage (BAL) led to the detection of Conclusions: Immunosuppression can lead to several associated infectious diseases. Before starting anti-TNF or anti-interleukin therapy, latent tuberculosis must always be ruled out. The need for cortisone therapy in immunocompromised people with COVID-19 disease must be evaluated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.